Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2025 Filed Feb 19, 2025 02:06 UTC |
Swanson James D.EVP, CIO
|
Tax withholdingCommon Stock | 152 | $155.26 | $23,599.52 |
DisclosureSEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · nonDerivative · entry 2 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,866.59 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionPerformance Share Units · Derivative | 15,465 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · derivative · entry 12 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,465 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F5 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionRestricted Share Units · Derivative | 4,053 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · derivative · entry 10 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,053 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Tax withholdingCommon Stock | 7,911 | $156.71 | $1,239,732.81 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 8 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,013.001 F6 · shares: Shares withheld for payment of taxes upon vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionCommon Stock | 15,465 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 7 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,924.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Tax withholdingCommon Stock | 1,348 | $156.71 | $211,245.08 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 4 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,516.001 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionCommon Stock | 4,053 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,864.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Tax withholdingCommon Stock | 410 | $155.26 | $63,656.60 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,811.001 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionPerformance Share Units · Derivative | 15,316 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · derivative · entry 14 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. The PSUs convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. The PSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 4,014 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · derivative · entry 12 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,014 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 6,661 | $156.71 | $1,043,845.31 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 8 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 F6 · shares: Shares withheld for payment of taxes upon vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 15,316 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 7 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. The PSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 1,144 | $156.71 | $179,276.24 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,142 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 4,014 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 507 | $155.26 | $78,716.82 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,272 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionPerformance Share Units · Derivative | 5,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · derivative · entry 14 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. The PSUs convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. The PSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionRestricted Share Units · Derivative | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · derivative · entry 12 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 2,393 | $156.71 | $375,007.03 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 8 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,280.8735 F6 · shares: Shares withheld for payment of taxes upon vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 5,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 7 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,673.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. The PSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 480 | $156.71 | $75,220.80 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 4 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,429.8735 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 3 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,909.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 223 | $155.26 | $34,622.98 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,379.8735 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionRestricted Share Units · Derivative | 1,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · derivative · entry 8 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,765 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 639 | $156.71 | $100,137.69 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 4 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,472 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 1,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 3 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 193 | $155.26 | $29,965.18 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,346 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:46 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionPerformance Share Units · Derivative | 2,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000062 · wk-form4_1739933175.xml · derivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,806 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:46 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 1,015 | $156.71 | $159,060.65 |
DisclosureSEC source: 0000200406-25-000062 · wk-form4_1739933175.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,889 F2 · shares: Shares withheld for payment of taxes upon vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:46 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 2,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000062 · wk-form4_1739933175.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 01:58 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionRestricted Share Units · Derivative | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · derivative · entry 9 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408 Underlying: Common Stock · 408 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 01:58 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionCommon Stock | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · nonDerivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:01 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionRestricted Share Units · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · derivative · entry 11 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312 Underlying: Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:01 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:02 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionRestricted Share Units · Derivative | 3,470 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · derivative · entry 10 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,469 Underlying: Common Stock · 3,470 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:02 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 3,470 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:03 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · derivative · entry 9 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 651 Underlying: Common Stock · 651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:03 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionCommon Stock | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · nonDerivative · entry 1 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:05 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · derivative · entry 9 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410 Underlying: Common Stock · 411 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:05 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Exercise / conversionCommon Stock | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · nonDerivative · entry 1 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:06 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionRestricted Share Units · Derivative | 447 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · derivative · entry 9 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447 Underlying: Common Stock · 447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:06 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionCommon Stock | 447 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · nonDerivative · entry 1 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,018.59 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionRestricted Share Units · Derivative | 1,302 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · derivative · entry 9 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,302 Underlying: Common Stock · 1,302 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionCommon Stock | 1,302 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,221.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · derivative · entry 11 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779 Underlying: Common Stock · 1,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionRestricted Share Units · Derivative | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · derivative · entry 11 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 651 Underlying: Common Stock · 651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,602.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionRestricted Share Units · Derivative | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · derivative · entry 7 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499 Underlying: Common Stock · 499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F5 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:38 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
GrantPerformance Share Units · Derivative | 2,910 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000017 · wk-form4_1739399922.xml · derivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,910 Underlying: Common Stock · 2,910 shares Expires not disclosed F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.